Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis
MAD therapy for OSAHS in patients with Friedman Stages 2 to 4 is an effective treatment in 72% of cases and should be considered as an initial treatment option within this subset of patients, inclusive of those with initially severe, moderate, and mild OSAHS.
Authors
- Nainika Nanda (ORCID: https://orcid.org/0000-0002-1043-8546)
- Aaron J. Robertson (ORCID: https://orcid.org/0000-0003-1761-5303)
- David C. Upton
Institutions
- University of Wisconsin–Madison (US)
- University of California, Los Angeles (US)
Publication Details
- Journal
- Annals of Otology Rhinology & Laryngology
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1177/00034894251334725
- Citations
- 3
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 3.49